Log in
Enquire now
‌

US Patent 11559508 Pharmaceutical compositions comprising POH derivatives and methods of use

Patent 11559508 was granted and assigned to NEONC Technologies on January, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
NEONC Technologies
NEONC Technologies
0
Current Assignee
NEONC Technologies
NEONC Technologies
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115595080
Patent Inventor Names
Thomas Chen0
Satish Puppali0
Daniel Levin0
Date of Patent
January 24, 2023
0
Patent Application Number
166065200
Date Filed
April 18, 2018
0
Patent Primary Examiner
‌
Kevin E. Weddington
0
CPC Code
‌
A61K 47/55
0
‌
A61K 31/045
0
‌
A61K 31/20
0

The present invention provides for a method of treating a disease such as cancer, comprising the step of administering to a patient a therapeutically effective amount of a perillyl alcohol derivative such as a perillyl alcohol ester, or an isoperillyl alcohol derivative such as an isoperillyl alcohol ester. The derivative may be a perillyl alcohol or an isoperillyl alcohol conjugated with a therapeutic agent such as valproic acid. The route of administration may vary, including inhalation, intranasal, oral, transdermal, intravenous, subcutaneous or intramuscular injection.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11559508 Pharmaceutical compositions comprising POH derivatives and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.